Companies: 10,795·Total market cap: $144.5T
Freeline Therapeutics Holdings plc

Freeline Therapeutics Holdings plc

FRLNNASDAQHealthcare
$6.49
+$0.01(+0.15%)
Market Cap$28283096
P/E Ratio
52W High$8.745
52W Low$2.11

Freeline Therapeutics Holdings plc(FRLN)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

frln · 股价预测 · 7 位分析师(近3月)· FMP · 更新于 2025年1月9日

分析师评级与共识

基于过去 3 个月内 7 位华尔街分析师

SellBuy

Hold

7 位分析师

共识

评级分布

Strong Buy
0
Buy
2
Hold
5
Sell
0
Strong Sell
0
合计: 7 · 买入占比: 28.6%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $6.48

Freeline Therapeutics Holdings plc(FRLN)的分析师共识为 Hold,基于过去 3 个月内 7 位华尔街分析师的评级。FRLN 的 12 个月平均目标价为 $0.00,相对当前价 $6.48 代表 +0.0% 的潜在上行空间。

短期股价预测

⚠️ 短期模型暂不可用——近期成交量过低,信号不可靠。

长期股价预测

⚠️ 长期模型暂不可用——成交量过低,信号不可靠。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BULLISH

Based on 14 technical indicators

64%15%21%
9Buy
2Neutral
3Sell
RSI (14)77.8Overbought
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · FRLN · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$6.48SELL
MA 10$6.48SELL
MA 20$6.46BUY
MA 50$6.42BUY
MA 100$5.86BUY
MA 200$0.00NEUTRAL
Current $FRLN · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$6.48BUY
EMA 10$6.48BUY
EMA 20$6.46BUY
EMA 50$6.31BUY
EMA 100$5.83BUY
EMA 200$0.00NEUTRAL
Current $FRLN · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
HC Wainwright & Co.2023-11-28
Downgrade ↓
BuyNeutral
Wedbush2023-10-18
Downgrade ↓
OutperformNeutral
Wedbush2023-10-17
Downgrade ↓
OutperformNeutral
HC Wainwright & Co.2023-08-17
Maintains
BuyBuy
HC Wainwright & Co.2023-08-16
Maintains
BuyBuy
Stifel2023-08-16
Maintains
HoldHold
Stifel2023-08-15
Maintains
HoldHold
HC Wainwright & Co.2023-08-01
Maintains
BuyBuy
HC Wainwright & Co.2023-07-31
Maintains
BuyBuy
Stifel2023-06-01
Maintains
HoldHold

Wall Street analysts have recently issued updated ratings on Freeline Therapeutics Holdings plc (FRLN) stock. Of the recent 20 rating actions, 1 were upgrades and 6 were downgrades. 7 analysts currently cover FRLN.

分析师推荐趋势

Buy ratings00
Hold ratings11
Sell ratings00

FRLN analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$1M

Revenue Next Year

$1M

↓ 2.8% YoY

EPS This Year

$-12.16

EPS Next Year

$-0.52

↓ 95.7% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast FRLN EPS of $-12.16 for the current fiscal year, based on estimates from 0 analysts. The FRLN revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

FRLN 股价预测由两类独立数据源支撑:来自 7 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。FRLN 的共识目标价为 $0.00(+0.0% 上行空间),分析师共识为 Hold。

Freeline Therapeutics Holdings plc 在 NASDAQ 上市,代码 FRLN。FRLN 在 2027 年的整体展望偏中性/分化,在覆盖分析师中约 29% 对应 Hold 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

FRLN 预测 · 8 个问题

根据 7 位华尔街分析师,FRLN 的 12 个月平均目标价为 $0.00,最高 $0.00、最低 $0.00。若有图表,中位目标价可在上方查看。相对当前价 $6.48,隐含约 +0.0% 的上行空间。

FRLN 目标价FRLN 分析师目标价FRLN 12个月目标价目标价 FRLN

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.